Related Experiment Videos
Isoindolinone enantiomers having affinity for the dopamine D4 receptor
T R Belliotti1, W A Brink, S R Kesten
1Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Co., Ann Arbor, MI 48105, USA.
Bioorganic & Medicinal Chemistry Letters
|January 5, 1999
Summary
Researchers developed novel isoindolinones with potent dopamine D4 receptor affinity. This discovery offers a metabolically stable alternative to existing dopamine D4 ligands like PD 108635.
Area of Science:
- Medicinal Chemistry
- Neuroscience
- Pharmacology
Background:
- PD 108635 is a known potent ligand for the dopamine D4 receptor.
- The benzylic alcohol moiety in PD 108635 presents metabolic instability concerns.
- There is a need for metabolically stable dopamine D4 receptor ligands.
Purpose of the Study:
- To design and synthesize novel compounds that retain dopamine D4 receptor affinity.
- To replace the metabolically labile benzylic alcohol in PD 108635 with a more stable group.
- To explore the structure-activity relationship of isoindolinone derivatives as dopamine D4 ligands.
Main Methods:
- Medicinal chemistry synthesis of isoindolinone analogs.
- In vitro binding assays to determine dopamine D4 receptor affinity.
- Metabolic stability assessments of lead compounds.
Main Results:
- A series of isoindolinones were successfully synthesized.
- Several isoindolinone derivatives demonstrated significant dopamine D4 receptor affinity.
- The isoindolinone scaffold proved to be a viable replacement for the benzylic alcohol moiety, offering improved metabolic stability.
Conclusions:
- Isoindolinones represent a promising new class of dopamine D4 receptor ligands.
- These compounds offer potential therapeutic advantages due to enhanced metabolic stability.
- Further investigation into isoindolinones is warranted for potential neurological applications.